Abstract

Nilotinib induced bone marrow CD34+/lin-Ph+ cells early clearance in newly diagnosed CP-chronic myeloid leukemia.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Evaluation of Residual CD34+/Ph+ Stem Cells In Chronic Myeloid Leukemia Patients In Complete Cytogenetic Response during First Line Nilotinib Therapy.
Monica Bocchia ...
Blood | VOL. 116
Monica Bocchia, et. al.Monica Bocchia ...
19 Nov 2010
Jak-2 and Nfkbia Gene Expression Play a Strategic Role in Chronic Myeloid Leukemia (CML) Molecular Response during Early Nilotinib Treatment: The PhilosoPhi34 Data
Ester Pungolino ...
Blood | VOL. 132
Ester Pungolino, et. al.Ester Pungolino ...
29 Nov 2018
Nilotinib Deregulates Cell Cycle Checkpoints, ABC Transporters Genes and JAK-STAT Signaling Pathway of CD34+/Lin- Cells in Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients after 12 Months of Treatment
Alessandra Trojani ...
Blood | VOL. 132
Alessandra Trojani, et. al.Alessandra Trojani ...
29 Nov 2018
Evaluation of residual CD34+Ph+ progenitor cells in chronic myeloid leukemia patients who have complete cytogenetic response during first‐line nilotinib therapy
Marzia Defina ... Claudia Baratè
Cancer | VOL. 118
Marzia Defina, et. al.Marzia Defina ... Claudia Baratè
19 Apr 2012
View more papers

More From: American journal of hematology

Paper Title
Journal
Date
Author
Safety and efficacy of baricitinib in steroid-resistant or relapsed immune thrombocytopenia: An open-label pilot study.
Peng Zhao ... Xiao-Hui Zhang
American journal of hematology | VOL. -
Peng Zhao, et. al.Peng Zhao ... Xiao-Hui Zhang
09 Jul 2024
Immune thrombocytopenia newly diagnosed during pregnancy: Outcome for mothers and neonates and comparison with chronic immune thrombocytopenia during pregnancy.
Stéphanie Guillet ... Bertrand Godeau
American journal of hematology | VOL. -
Stéphanie Guillet, et. al.Stéphanie Guillet ... Bertrand Godeau
09 Jul 2024
Evaluating the role of Day 14 bone marrow biopsy and European LeukemiaNet risk classification in predicting overall and relapse-free survival in acute myeloid leukemia.
Metodi Balev ... Douglas Tremblay
American journal of hematology | VOL. -
Metodi Balev, et. al.Metodi Balev ... Douglas Tremblay
05 Jul 2024
At what COST?: A prospective longitudinal cohort assessment of financial toxicity, quality of life, and associated risk factors in patients with plasma cell disorders.
Rahma M Warsame ... Amylou C Dueck
American journal of hematology | VOL. -
Rahma M Warsame, et. al.Rahma M Warsame ... Amylou C Dueck
05 Jul 2024
View more papers